Sun Pharma Advanced Research Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2025 ,inter alia, to consider and approve Audited ....
SPARC · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
SPARC has informed the stock exchanges that its Board of Directors will meet on Monday, May 19, 2025. The main agenda is to approve the Audited Standalone and Consolidated Financial Results for the quarter and financial year ended March 31, 2025, meaning FY25 results will be announced that day. Separately, the Board will also consider a proposal to raise funds through permissible modes (such as equity, debt, or other instruments) and will seek shareholder approval for this at the upcoming Annual General Meeting. The trading window for insiders remains closed from April 1, 2025 until May 21, 2025, covering the results announcement period.
This is a routine pre-results intimation with no actual numbers disclosed yet, so it should not move the stock on its own. However, the mention of a possible fund-raising plan is a forward-looking signal — investors should watch the May 19 outcome closely, as a decision to raise fresh capital could lead to dilution or added debt depending on the mode chosen.